Related references
Note: Only part of the references are listed.Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder
F. W. Lohoff et al.
PHARMACOGENOMICS JOURNAL (2013)
Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder
F. W. Lohoff et al.
PHARMACOGENOMICS JOURNAL (2013)
Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome
Rodney C. Samaco et al.
NATURE GENETICS (2012)
Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y
Mallory E. Bowers et al.
PHYSIOLOGY & BEHAVIOR (2012)
Pharmacogenetics of antidepressant drugs: current clinical practice and future directions
Sneha Narasimhan et al.
PHARMACOGENOMICS (2012)
Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder
Sneha Narasimhan et al.
PSYCHIATRY RESEARCH (2012)
Exploring the Comorbidity of Anxiety and Substance Use Disorders
Sonja Pasche
CURRENT PSYCHIATRY REPORTS (2012)
Pharmacological treatment of generalized anxiety disorder
Jennifer A. Reinhold et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorder
Sneha Narasimhan et al.
NEUROSCIENCE LETTERS (2011)
Pharmacogenomics of the human μ-opioid receptor
Shinya Kasai et al.
PHARMACOGENOMICS (2011)
Association of Mu-Opioid Receptor Variants and Response to Citalopram Treatment in Major Depressive Disorder
Holly A. Garriock et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Time to Relapse After 6 and 12 Months' Treatment of Generalized Anxiety Disorder With Venlafaxine Extended Release
Karl Rickels et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models
Stephen D. Mague et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
HTR2A gene variation is involved in antidepressant treatment response
Susanne Lucae et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
A118G Polymorphism of OPRM1 Gene is Associated with Schizophrenia
Omar Sery et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment
Sonja Horstmann et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Relationship between anxiety disorders and opiate dependence-A systematic review of the literature: Implications for diagnosis and treatment
Melina Fatseas et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2010)
Refractory Generalized Anxiety Disorder
Mark H. Pollack
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response
Eric J. Peters et al.
PHARMACOGENETICS AND GENOMICS (2009)
Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women
Susan E. Kennedy et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment
FJ McMahon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Remission of generalized anxiety disorder: A review of the paroxetine clinical trials database
K Rickels et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors
SC Ribeiro et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy?
P Gorwood
EUROPEAN PSYCHIATRY (2004)
Opioid receptors regulate the extinction of Pavlovian fear conditioning
GP McNally et al.
BEHAVIORAL NEUROSCIENCE (2003)
Lack of association of a single-nucleotide polymorphism of the μ-opioid receptor gene with anxiety-related traits:: Results from a cross-sectional study of adults and a longitudinal study of children
AF Jorm et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder - A 6-month randomized controlled trial
AJ Gelenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Mice deficient for δ- and γ-opioid receptors exhibit opposing alterations of emotional responses
D Filliol et al.
NATURE GENETICS (2000)
Share Paper
